Agranulocytosis and citrobacter infection associated with jamu, a herbal remedy containing phenylbutazone [2]

Clinical Infectious Diseases

Volumn 40, Issue 12, 2005, Pages 1859-1860

  Paul, John ^a   Duncan, John R ^a   Sharp, Peter ^a   Norris, Andrew ^a   Siddiq, Mirza A ^a   Bacon, Clare ^a   Weighill, John ^a  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN; DEXAMETHASONE; DICLOFENAC; GENTAMICIN; GLUCOSAMINE; HERBACEOUS AGENT; JAMU; METRONIDAZOLE; PHENYLBUTAZONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TIMENTIN; UNCLASSIFIED DRUG; ZOPICLONE;

AGED; AGRANULOCYTOSIS; CASE REPORT; CELLULITIS; CITROBACTER KOSERI; DYSPHAGIA; FEMALE; FEVER; GRAM NEGATIVE INFECTION; HUMAN; LETTER; OSTEOARTHRITIS; PRIORITY JOURNAL; SORE THROAT;

AGED; AGRANULOCYTOSIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CITROBACTER KOSERI; DRUG CONTAMINATION; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; PHENYLBUTAZONE; PHYTOTHERAPY; PLANT PREPARATIONS;

EID: 20444384428     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/430447     Document Type: Letter

References (5)

1. Giam YC, Tham SN, Tan T, Lim A. Drug eruptions from phenylbutazone in jamu. Ann Acad Med Singapore 1986; 15:118-21.
2. Limyati DA, Juniar BL. Jamu gendong, a kind of traditional medicine in Indonesia; the microbial contamination of its raw materials and end product. J Ethnopharmacol 1998; 63: 201-8.
3. ABPI compendium of data sheets and summaries of product characteristics 1999-2000. London: Datapharm, 1999.
4. Pennington D, Rush B, Castaldi P, eds. De gruchy's clinical haematology in medical practice. 4th ed. Oxford, United Kingdom: Blackwell, 1980.
5. Ciucci AG. A review of spontaneously reported adverse drug reactions with diclofenac sodium (Voltarol). Rheumatol Rehabil 1979;Suppl 2: 116-21.